Bespoke Extracts SEC Filings

Bespoke Extracts, Inc. reported Q3 2025 results with stronger sales but continued losses and liquidity pressure. Sales were $467,945 (up from $277,471), generating gross profit of $234,175. Operating loss narrowed to $53,891, and net loss was $78,088 or $0.01 per share.

For the first nine months, sales reached $1,121,657 with gross profit of $542,453 and a net loss of $543,715. Operating expenses declined year over year as stock-based compensation fell, partly offset by higher salaries.

Liquidity remains constrained: cash was $16,743, current liabilities were $1,872,581, and the company reported a working capital deficit of $1,675,749 and a stockholders’ deficit of $2,595,508. Management disclosed “substantial doubt” about the ability to continue as a going concern. Debt includes 15% Senior Secured Notes and a related‑party note of $849,500 (maturity extended to June 30, 2027 after quarter‑end). The company also reported material weaknesses in disclosure controls.